Naa12 compensates for Naa10 in mice in the amino-terminal acetylation pathway

  1. Hyae Yon Kweon
  2. Mi-Ni Lee  Is a corresponding author
  3. Max Dorfel
  4. Seungwoon Seo
  5. Leah Gottlieb
  6. Thomas PaPazyan
  7. Nina McTiernan
  8. Rasmus Ree
  9. David Bolton
  10. Andrew Garcia
  11. Michael Flory
  12. Jonathan Crain
  13. Alison Sebold
  14. Scott Lyons
  15. Ahmed Ismail
  16. Elaine Marchi
  17. Seong-keun Sonn
  18. Se-Jin Jeong
  19. Sejin Jeon
  20. Shinyeong Ju
  21. Simon J Conway
  22. Taesoo Kim
  23. Hyun-Seok Kim
  24. Cheolju Lee
  25. Tae-Young Roh
  26. Thomas Arnesen
  27. Ronen Marmorstein
  28. Gootaeg Oh  Is a corresponding author
  29. Gholson J Lyon  Is a corresponding author
  1. Ewha Womans University, Republic of Korea
  2. Stanley Institute for Cognitive Genomics, Cold Spring Harbor Laboratory, United States
  3. Perelman School of Medicine, University of Pennsylvania, United States
  4. University of Bergen, Norway
  5. Department of Molecular Biology, New York State Institute for Basic Research in Developmental Disabilities, United States
  6. New York State Institute for Basic Research in Developmental Disabilities, United States
  7. Washington University School of Medicine, United States
  8. Korea Institute of Science and Technology, Republic of Korea
  9. Indiana University School of Medicine, United States
  10. Pohang University of Science and Technology, Republic of Korea
  11. George A Jervis Clinic, New York State Institute for Basic Research in Developmental Disabilities, United States

Abstract

Amino-terminal acetylation is catalyzed by a set of N-terminal acetyltransferases (NATs). The NatA complex (including X-linked Naa10 and Naa15) is the major acetyltransferase, with 40-50% of all mammalian proteins being potential substrates. However, the overall role of amino-terminal acetylation on a whole-organism level is poorly understood, particularly in mammals. Male mice lacking Naa10 show no globally apparent in vivo amino-terminal acetylation impairment and do not exhibit complete embryonic lethality. Rather Naa10 nulls display increased neonatal lethality, and the majority of surviving undersized mutants exhibit a combination of hydrocephaly, cardiac defects, homeotic anterior transformation, piebaldism and urogenital anomalies. Naa12 is a previously unannotated Naa10-like paralogue with NAT activity that genetically compensates for Naa10. Mice deficient for Naa12 have no apparent phenotype, whereas mice deficient for Naa10 and Naa12 display embryonic lethality. The discovery of Naa12 adds to the currently known machinery involved in amino-terminal acetylation in mice.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files.Mass spectrometry data were uploaded to PRIDE under Project Name: Naa10 mutant mouse N-terminome LC-MS, Project accession: PXD026410.

The following data sets were generated

Article and author information

Author details

  1. Hyae Yon Kweon

    Department of Life Science and College of Natural Sciences,, Ewha Womans University, Seoul, Republic of Korea
    Competing interests
    The authors declare that no competing interests exist.
  2. Mi-Ni Lee

    Department of Life Science and College of Natural Sciences, Ewha Womans University, Seoul, Republic of Korea
    For correspondence
    minilee@kribb.re.kr
    Competing interests
    The authors declare that no competing interests exist.
  3. Max Dorfel

    Genetics, Stanley Institute for Cognitive Genomics, Cold Spring Harbor Laboratory, Woodbury, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Seungwoon Seo

    Department of Life Science and College of Natural Sciences,, Ewha Womans University, Seoul, Republic of Korea
    Competing interests
    The authors declare that no competing interests exist.
  5. Leah Gottlieb

    Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Thomas PaPazyan

    Genetics, Stanley Institute for Cognitive Genomics, Cold Spring Harbor Laboratory, Woodbury, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Nina McTiernan

    Department of Biomedicine, University of Bergen, Bergen, Norway
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1749-6933
  8. Rasmus Ree

    Department of Biomedicine, University of Bergen, Bergen, Norway
    Competing interests
    The authors declare that no competing interests exist.
  9. David Bolton

    Department of Molecular Biology, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Andrew Garcia

    Human Genetics, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Michael Flory

    Research Design and Analysis Service, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Jonathan Crain

    Genetics, Stanley Institute for Cognitive Genomics, Cold Spring Harbor Laboratory, Woodbury, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Alison Sebold

    Genetics, Stanley Institute for Cognitive Genomics, Cold Spring Harbor Laboratory, Woodbury, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. Scott Lyons

    Genetics, Stanley Institute for Cognitive Genomics, Cold Spring Harbor Laboratory, Woodbury, United States
    Competing interests
    The authors declare that no competing interests exist.
  15. Ahmed Ismail

    Genetics, Stanley Institute for Cognitive Genomics, Cold Spring Harbor Laboratory, Woodbury, United States
    Competing interests
    The authors declare that no competing interests exist.
  16. Elaine Marchi

    Human Genetics, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, United States
    Competing interests
    The authors declare that no competing interests exist.
  17. Seong-keun Sonn

    Department of Life Science and College of Natural Sciences,, Ewha Womans University, Seoul, Republic of Korea
    Competing interests
    The authors declare that no competing interests exist.
  18. Se-Jin Jeong

    Department of Medicine, Cardiovascular Division, Washington University School of Medicine, St. Louis, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6375-5334
  19. Sejin Jeon

    Department of Life Science and College of Natural Sciences,, Ewha Womans University, Seoul, Republic of Korea
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3819-3421
  20. Shinyeong Ju

    Center for Theragnosis, Korea Institute of Science and Technology, Seoul, Republic of Korea
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5483-4690
  21. Simon J Conway

    Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianopolis, United States
    Competing interests
    The authors declare that no competing interests exist.
  22. Taesoo Kim

    Department of Life Science and College of Natural Sciences, Ewha Womans University, Seoul, Republic of Korea
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3902-1058
  23. Hyun-Seok Kim

    Department of Life Science and College of Natural Sciences,, Ewha Womans University, Seoul, Republic of Korea
    Competing interests
    The authors declare that no competing interests exist.
  24. Cheolju Lee

    Center for Theragnosis, Korea Institute of Science and Technology, Seoul, Republic of Korea
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8482-4696
  25. Tae-Young Roh

    Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5833-0844
  26. Thomas Arnesen

    Department of Biomedicine, University of Bergen, Bergen, Norway
    Competing interests
    The authors declare that no competing interests exist.
  27. Ronen Marmorstein

    Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4373-4752
  28. Gootaeg Oh

    Department of Life Science and College of Natural Sciences,, Ewha Womans University, Seoul, Republic of Korea
    For correspondence
    gootaeg@ewha.ac.kr
    Competing interests
    The authors declare that no competing interests exist.
  29. Gholson J Lyon

    Human Genetics, George A Jervis Clinic, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, United States
    For correspondence
    gholsonjlyon@gmail.com
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5869-0716

Funding

National Research Foundation of Korea (2020R1A3B2079811)

  • Gootaeg Oh

Norwegian Cancer Society (PR-2009-0222)

  • Thomas Arnesen

National Research Foundation of Korea (2017RIDIAB03032286)

  • Mi-Ni Lee

National Research Foundation of Korea (2020RICIC1007686)

  • Mi-Ni Lee

National Institute of General Medical Sciences (R35GM133408)

  • Gholson J Lyon

National Institute of General Medical Sciences (R35GM118090)

  • Ronen Marmorstein

Research Council of Norway (Project 249843)

  • Thomas Arnesen

National Institutes of Health (Project 249843)

  • Simon J Conway

Norwegian Health Authorities of Western Norway (912176)

  • Thomas Arnesen

Norwegian Health Authorities of Western Norway (F-12540-D11382)

  • Thomas Arnesen

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All experiments were performed in accordance with guidelines of International Animal Care and Use Committee (IACUC) of Ewha Womans University (protocol #18 012)012), Cold Spring Harbor L aboratory (CSHL) protocol # 579961 18 , and Institute for Basic Research in Developmental Disabilities (IBR) (protocol #456).

Copyright

© 2021, Kweon et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,349
    views
  • 188
    downloads
  • 9
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Hyae Yon Kweon
  2. Mi-Ni Lee
  3. Max Dorfel
  4. Seungwoon Seo
  5. Leah Gottlieb
  6. Thomas PaPazyan
  7. Nina McTiernan
  8. Rasmus Ree
  9. David Bolton
  10. Andrew Garcia
  11. Michael Flory
  12. Jonathan Crain
  13. Alison Sebold
  14. Scott Lyons
  15. Ahmed Ismail
  16. Elaine Marchi
  17. Seong-keun Sonn
  18. Se-Jin Jeong
  19. Sejin Jeon
  20. Shinyeong Ju
  21. Simon J Conway
  22. Taesoo Kim
  23. Hyun-Seok Kim
  24. Cheolju Lee
  25. Tae-Young Roh
  26. Thomas Arnesen
  27. Ronen Marmorstein
  28. Gootaeg Oh
  29. Gholson J Lyon
(2021)
Naa12 compensates for Naa10 in mice in the amino-terminal acetylation pathway
eLife 10:e65952.
https://doi.org/10.7554/eLife.65952

Share this article

https://doi.org/10.7554/eLife.65952

Further reading

    1. Chromosomes and Gene Expression
    2. Developmental Biology
    Valentin Babosha, Natalia Klimenko ... Oksana Maksimenko
    Research Article

    The male-specific lethal complex (MSL), which consists of five proteins and two non-coding roX RNAs, is involved in the transcriptional enhancement of X-linked genes to compensate for the sex chromosome monosomy in Drosophila XY males compared with XX females. The MSL1 and MSL2 proteins form the heterotetrameric core of the MSL complex and are critical for the specific recruitment of the complex to the high-affinity ‘entry’ sites (HAS) on the X chromosome. In this study, we demonstrated that the N-terminal region of MSL1 is critical for stability and functions of MSL1. Amino acid deletions and substitutions in the N-terminal region of MSL1 strongly affect both the interaction with roX2 RNA and the MSL complex binding to HAS on the X chromosome. In particular, substitution of the conserved N-terminal amino-acids 3–7 in MSL1 (MSL1GS) affects male viability similar to the inactivation of genes encoding roX RNAs. In addition, MSL1GS binds to promoters such as MSL1WT but does not co-bind with MSL2 and MSL3 to X chromosomal HAS. However, overexpression of MSL2 partially restores the dosage compensation. Thus, the interaction of MSL1 with roX RNA is critical for the efficient assembly of the MSL complex on HAS of the male X chromosome.

    1. Computational and Systems Biology
    2. Developmental Biology
    Rosalío Reyes, Arthur D Lander, Marcos Nahmad
    Research Article Updated

    Understanding the principles underlying the design of robust, yet flexible patterning systems is a key problem in developmental biology. In the Drosophila wing, Hedgehog (Hh) signaling determines patterning outputs using dynamical properties of the Hh gradient. In particular, the pattern of collier (col) is established by the steady-state Hh gradient, whereas the pattern of decapentaplegic (dpp), is established by a transient gradient of Hh known as the Hh overshoot. Here, we use mathematical modeling to suggest that this dynamical interpretation of the Hh gradient results in specific robustness and precision properties. For instance, the location of the anterior border of col, which is subject to self-enhanced ligand degradation is more robustly specified than that of dpp to changes in morphogen dosage, and we provide experimental evidence of this prediction. However, the anterior border of dpp expression pattern, which is established by the overshoot gradient is much more precise to what would be expected by the steady-state gradient. Therefore, the dynamical interpretation of Hh signaling offers tradeoffs between robustness and precision to establish tunable patterning properties in a target-specific manner.